Literature DB >> 21467230

Metabolites of a tobacco-specific lung carcinogen in children exposed to secondhand or thirdhand tobacco smoke in their homes.

Janet L Thomas1, Hongfei Guo, Steven G Carmella, Silvia Balbo, Shaomei Han, Andrew Davis, Andrea Yoder, Sharon E Murphy, Larry C An, Jasjit S Ahluwalia, Stephen S Hecht.   

Abstract

BACKGROUND: People exposed to secondhand tobacco smoke (SHS) inhale the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) which is metabolized to NNAL and its glucuroniders. These urinary metabolites, termed total NNAL, can be quantified. A related compound, iso-NNAL, has been proposed as a biomarker for exposure to smoke constituent residues on surfaces (thirdhand tobacco smoke). There is limited information in the literature on levels of total NNAL in children exposed to SHS.
METHODS: We recruited 79 parent--child dyads from homes where the enrolled parent was a cigarette smoker and visited their homes. Parents were asked questions, home ambient air quality was evaluated, and children provided urine samples. Urine was analyzed for total NNAL, total cotinine, total nicotine, and iso-NNAL.
RESULTS: Ninety percent of the children had detectable total NNAL in urine; total nicotine and total cotinine were also detected in most samples. There were significant positive relationships between biomarker levels and exposure of children in the home. Levels were highest in homes with no smoking restrictions. African American children had significantly higher levels than other children. iso-NNAL was not detected in any urine sample.
CONCLUSIONS: There was nearly universal exposure of children to the lung carcinogen NNK, due mainly to exposure to SHS from adult smokers in their homes. IMPACT: Homes with adult smokers should adopt restrictions to protect their children from exposure to a potent lung carcinogen. ©2011 AACR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21467230      PMCID: PMC3111852          DOI: 10.1158/1055-9965.EPI-10-1027

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  21 in total

1.  Tobacco smoke and involuntary smoking.

Authors: 
Journal:  IARC Monogr Eval Carcinog Risks Hum       Date:  2004

Review 2.  Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines.

Authors:  S S Hecht
Journal:  Chem Res Toxicol       Date:  1998-06       Impact factor: 3.739

3.  Urine concentrations of a tobacco-specific nitrosamine carcinogen in the U.S. population from secondhand smoke exposure.

Authors:  John T Bernert; James L Pirkle; Yang Xia; Ram B Jain; David L Ashley; Eric J Sampson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-09-10       Impact factor: 4.254

4.  Environmental tobacco smoke and risk of respiratory cancer and chronic obstructive pulmonary disease in former smokers and never smokers in the EPIC prospective study.

Authors:  P Vineis; L Airoldi; F Veglia; L Olgiati; R Pastorelli; H Autrup; A Dunning; S Garte; E Gormally; P Hainaut; C Malaveille; G Matullo; M Peluso; K Overvad; A Tjonneland; F Clavel-Chapelon; H Boeing; V Krogh; D Palli; S Panico; R Tumino; B Bueno-De-Mesquita; P Peeters; G Berglund; G Hallmans; R Saracci; E Riboli
Journal:  BMJ       Date:  2005-01-28

5.  Analysis of total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine.

Authors:  Steven G Carmella; Shaomei Han; Anne Fristad; Yiying Yang; Stephen S Hecht
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-11       Impact factor: 4.254

6.  Selected ion monitoring method for determination of nicotine, cotinine and deuterium-labeled analogs: absence of an isotope effect in the clearance of (S)-nicotine-3',3'-d2 in humans.

Authors:  P Jacob; L Yu; M Wilson; N L Benowitz
Journal:  Biol Mass Spectrom       Date:  1991-05

7.  A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke.

Authors:  S S Hecht; S G Carmella; S E Murphy; S Akerkar; K D Brunnemann; D Hoffmann
Journal:  N Engl J Med       Date:  1993-11-18       Impact factor: 91.245

Review 8.  Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer.

Authors:  Stephen S Hecht
Journal:  Carcinogenesis       Date:  2002-06       Impact factor: 4.944

9.  Measurement of environmental tobacco smoke exposure among adults with asthma.

Authors:  M D Eisner; P P Katz; E H Yelin; S K Hammond; P D Blanc
Journal:  Environ Health Perspect       Date:  2001-08       Impact factor: 9.031

10.  Children's exposure to environmental tobacco smoke: using diverse exposure metrics to document ethnic/racial differences.

Authors:  Ken Sexton; John L Adgate; Timothy R Church; Stephen S Hecht; Gurumurthy Ramachandran; Ian A Greaves; Ann L Fredrickson; Andrew D Ryan; Steven G Carmella; Mindy S Geisser
Journal:  Environ Health Perspect       Date:  2004-03       Impact factor: 9.031

View more
  15 in total

1.  The ratio of a urinary tobacco-specific lung carcinogen metabolite to cotinine is significantly higher in passive than in active smokers.

Authors:  Rachel I Vogel; Steven G Carmella; Irina Stepanov; Dorothy K Hatsukami; Stephen S Hecht
Journal:  Biomarkers       Date:  2011-08-03       Impact factor: 2.658

2.  The relationship between nicotine metabolism and nicotine and carcinogen exposure among American Indian commercial cigarette smokers and electronic nicotine delivery system users.

Authors:  Dana Mowls Carroll; Theodore L Wagener; Lancer D Stephens; Lacy S Brame; David M Thompson; Laura A Beebe
Journal:  Addict Behav       Date:  2018-10-28       Impact factor: 3.913

3.  Potential contributions of the tobacco nicotine-derived nitrosamine ketone (NNK) in the pathogenesis of steatohepatitis in a chronic plus binge rat model of alcoholic liver disease.

Authors:  Valerie Zabala; Ming Tong; Rosa Yu; Teresa Ramirez; Emine B Yalcin; Silvia Balbo; Elizabeth Silbermann; Chetram Deochand; Kavin Nunez; Stephen Hecht; Suzanne M de la Monte
Journal:  Alcohol Alcohol       Date:  2015-01-24       Impact factor: 2.826

4.  It is time to regulate carcinogenic tobacco-specific nitrosamines in cigarette tobacco.

Authors:  Stephen S Hecht
Journal:  Cancer Prev Res (Phila)       Date:  2014-05-07

Review 5.  Protecting the world from secondhand tobacco smoke exposure: where do we stand and where do we go from here?

Authors:  Joaquin Barnoya; Ana Navas-Acien
Journal:  Nicotine Tob Res       Date:  2012-10-15       Impact factor: 4.244

6.  Thirdhand tobacco smoke: a tobacco-specific lung carcinogen on surfaces in smokers' homes.

Authors:  Janet L Thomas; Stephen S Hecht; Xianghua Luo; Xun Ming; Jasjit S Ahluwalia; Steven G Carmella
Journal:  Nicotine Tob Res       Date:  2013-07-26       Impact factor: 4.244

7.  Children's exposure to secondhand and thirdhand smoke carcinogens and toxicants in homes of hookah smokers.

Authors:  Nada O F Kassem; Reem M Daffa; Sandy Liles; Sheila R Jackson; Noura O Kassem; Maram A Younis; Setoo Mehta; Menglan Chen; Peyton Jacob; Steve G Carmella; Dale A Chatfield; Neal L Benowitz; Georg E Matt; Stephen S Hecht; Melbourne F Hovell
Journal:  Nicotine Tob Res       Date:  2014-03-03       Impact factor: 4.244

8.  Biomarkers of Exposure in ENDS Users, Smokers, and Dual Users of American Indian Descent.

Authors:  Dana Mowls Carroll; Theodore L Wagener; Jennifer D Peck; Lacy S Brame; David M Thompson; Lancer D Stephens; Janis E Campbell; Laura A Beebe
Journal:  Tob Regul Sci       Date:  2018-03

9.  Exposure and Metabolic Activation Biomarkers of Carcinogenic Tobacco-Specific Nitrosamines.

Authors:  Stephen S Hecht; Irina Stepanov; Steven G Carmella
Journal:  Acc Chem Res       Date:  2015-12-17       Impact factor: 22.384

10.  Applying Tobacco, Environmental, and Dietary-Related Biomarkers to Understand Cancer Etiology and Evaluate Prevention Strategies.

Authors:  Lisa A Peterson; Silvia Balbo; Naomi Fujioka; Dorothy K Hatsukami; Stephen S Hecht; Sharon E Murphy; Irina Stepanov; Natalia Y Tretyakova; Robert J Turesky; Peter W Villalta
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-02-12       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.